Scholar Rock Holding (SRRK) Retained Earnings (2017 - 2026)
Scholar Rock Holding (SRRK) posted quarterly Retained Earnings of -$1.4 billion for Q1 2026, down 1090149.61% year-over-year from N/an in Q1 2025, and down 1496019.15% quarter-over-quarter from $94000.0 in Q4 2025.
Scholar Rock Holding (SRRK) Retained Earnings (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Retained Earnings history runs 10 years deep, the most recent figure standing at -$1.4 billion for Q1 2026.
- In Q1 2026, Retained Earnings fell 1090149.61% year-over-year to -$1.4 billion; the TTM figure through Mar 2026 stood at -$1.4 billion (down 1090149.61% YoY), while the FY2025 annual figure was $94000.0, up 100.01% from the prior year.
- Retained Earnings for Q1 2026 stood at -$1.4 billion, down from $94000.0 in the prior quarter.
- The five-year high for Retained Earnings was $555.5 million in Q1 2022, with the low at -$1.4 billion in Q1 2026.
- The 5-year median for Retained Earnings is -$329000.0 (2023), against an average of -$382.0 million.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings plunged 1256696.83% in 2024, then soared 358.0% in 2025.
- Scholar Rock Holding's Retained Earnings stood at -$510.6 million in 2022, then surged by 100.02% to $92000.0 in 2023, then sank by 1003051.09% to -$922.7 million in 2024, then soared by 100.01% to $94000.0 in 2025, then sank by 1496019.15% to -$1.4 billion in 2026.
- Business Quant data shows SRRK's Retained Earnings at -$1.4 billion in Q1 2026, $94000.0 in Q4 2025, and -$1.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Scholar Rock Holding | 6.39 Bn | 6.39 Bn | - | 1.77 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.77 Bn |
| Mar 31, 2026 | -1.41 Bn |
| Dec 31, 2025 | 94,000.00 |
| Sep 30, 2025 | -1.21 Bn |
| Jun 30, 2025 | -1.11 Bn |
| Mar 31, 2025 | 129,000.00 |
| Dec 31, 2024 | -922.72 Mn |
| Sep 30, 2024 | 128,000.00 |
| Jun 30, 2024 | -791.78 Mn |
| Mar 31, 2024 | -50,000.00 |
| Dec 31, 2023 | 92,000.00 |
| Sep 30, 2023 | -630.30 Mn |
| Jun 30, 2023 | -63,000.00 |
| Mar 31, 2023 | -329,000.00 |
| Dec 31, 2022 | -510.63 Mn |
| Sep 30, 2022 | -471.38 Mn |
| Jun 30, 2022 | -79,000.00 |
| Mar 31, 2022 | 555.51 Mn |
| Dec 31, 2021 | 548.20 Mn |
| Sep 30, 2021 | 527.44 Mn |